V
Vincent Le Moing
Researcher at University of Montpellier
Publications - 148
Citations - 6259
Vincent Le Moing is an academic researcher from University of Montpellier. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 34, co-authored 123 publications receiving 5166 citations. Previous affiliations of Vincent Le Moing include Institut de recherche pour le développement & French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
Changing profile of infective endocarditis: results of a 1-year survey in France.
Bruno Hoen,François Alla,Christine Selton-Suty,Isabelle Beguinot,Anne Bouvet,Serge Briançon,Jean-Paul Casalta,Nicolas Danchin,François Delahaye,Jerome Etienne,Vincent Le Moing,Catherine Leport,Jean-Luc Mainardi,Raymond Ruimy,François Vandenesch +14 more
TL;DR: Although the incidence of infective endocarditis has not changed, important changes in disease characteristics, treatment, and outcomes were noted.
Journal ArticleDOI
Preeminence of Staphylococcus aureus in Infective Endocarditis: A 1-Year Population-Based Survey
Christine Selton-Suty,Marie Célard,Vincent Le Moing,Thanh Doco-Lecompte,Catherine Chirouze,Bernard Iung,Christophe Strady,Matthieu Revest,François Vandenesch,Anne Bouvet,François Delahaye,François Alla,Xavier Duval,Xavier Duval,Bruno Hoen +14 more
TL;DR: S. aureus became both the leading cause and the most important prognostic factor of IE, and healthcare-associated IE appeared as a major subgroup of the disease.
Journal ArticleDOI
Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy.
Sophie Grabar,Vincent Le Moing,Cécile Goujard,Catherine Leport,Michel D. Kazatchkine,Dominique Costagliola,Laurence Weiss +6 more
TL;DR: Clinical outcomes are reported in a large cohort of patients in France 24 months after initiation of triple therapy that contained protease inhibitors, according to virologic and immunologic response at 6 months, and the long-term prognosis of patients exhibiting such discordant responses remains unknown.
Journal ArticleDOI
The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.
Vincent Di Martino,Pierre Rufat,Nathalie Boyer,Philippe Renard,Françoise Degos,Michèle Martinot-Peignoux,Sophie Matheron,Vincent Le Moing,F Vachon,Claude Degott,Dominique Valla,Patrick Marcellin +11 more
TL;DR: In this retrospective cohort study, HIV coinfection worsened the outcome of chronic hepatitis C, increasing both serum HCV‐RNA level and liver damage and decreasing sustained response to interferon therapy.
Journal ArticleDOI
Temporal Trends in Infective Endocarditis in the Context of Prophylaxis Guideline Modifications: Three Successive Population-Based Surveys
Xavier Duval,Xavier Duval,François Delahaye,François Alla,Pierre Tattevin,Jean-François Obadia,Vincent Le Moing,Thanh Doco-Lecompte,Marie Célard,Claire Poyart,Claire Poyart,Christophe Strady,Catherine Chirouze,Michelle Bes,Emmanuelle Cambau,Bernard Iung,Christine Selton-Suty,Bruno Hoen +17 more
TL;DR: Scaling down antibiotic prophylaxis indications was not associated with an increased incidence of oral streptococcal IE, and a focus on avoidance of S. aureus bacteremia in all patients, including those with no previously known valve disease, will be required to improve IE prevention.